Nature CommunicationsGenomicsPeer-reviewed journal article
Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries
Seyedeh Maryam ZekavatiD, Sanni RuotsalaineniD, Robert E. HandsakeriD, Maris AlveriD, Jonathan BloomiD, Timothy PoterbaiD, Cotton Seed, Jason ErnstiD, Mark D. ChaffiniD, J EngreitziD, Gina Marie PelosoiD, Ani W ManichaikuliD, Chaojie YangiD, Kathleen A. RyaniD, Mao Fu, W. Craig JohnsoniD, Michael Tsai, Matthew Jay BudoffiD, Ramachandran Srini VasaniD, L. Adrienne CupplesiD, Jerome I. RotteriD, Stephen S. RichiD, Wendy S. PostiD, Braxton D. MitchelliD, Adolfo CorreaiD, , Brian CusteriD
Abstract
Lipoprotein(a), Lp(a), is a modified low-density lipoprotein particle where apolipoprotein(a) (protein product of the LPA gene) is covalently attached to apolipoprotein B. Lp(a) is a highly heritable, causal risk factor for cardiovascular diseases and varies in concentrations across ancestries. To comprehensively delineate the inherited basis for plasma Lp(a), we performed deep-coverage whole genome sequencing in 8,392 individuals of European and African American ancestries. Through whole genome variant discovery and direct genotyping of all structural variants overlapping LPA, we quantified the 5.5kb kringle IV-2 copy number (KIV2-CN), a known LPA structural polymorphism, and developed a model for its imputation. Through common variant analysis, we discovered a novel locus (SORT1) associated with Lp(a)-cholesterol, and also genetic modifiers of KIV2-CN. Furthermore, in contrast to previous GWAS studies, we explain most of the heritability of Lp(a), observing Lp(a) to be 85% heritable among African Americans and 75% among Europeans, yet with notable inter-ethnic heterogeneity. Through analyses of aggregates of rare coding and non-coding variants with Lp(a)-cholesterol, we found the only genome-wide significant signal to be at a non-coding SLC22A3 intronic window also previously described to be associated with Lp(a); however, this association was mitigated by adjustment with KIV2-CN. Finally, using an additional imputation dataset (N=27,344), we performed Mendelian randomization of LPA variant classes, finding that genetically regulated Lp(a) is more strongly associated with incident cardiovascular diseases than directly measured Lp(a), and is significantly associated with measures of subclinical atherosclerosis in African Americans.
- organism: human
- assay: whole-genome sequencing
- research focus: GWAS / association mapping
- research focus: fine-mapping
- approach: statistical model
- Citations
- 105
- FWCI
- 13.25
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comprehensive analysis of the genetic variation in the LPA gene from short-read sequencing
Raphael O. Betschart, Georgios Koliopanos, … Andreas Ziegler·BioMedPeer-reviewed·Jun 4, 2024
- A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort
Natalie Telis, Hang Dai, … Kelly M. Schiabor Barrett·medRxiv·Nov 1, 2024
- Investigation of an LPA KIV-2 nonsense mutation in 11,000 individuals: the importance of linkage disequilibrium structure in LPA genetics.
Silvia Di Maio, Rebecca Grüneis, … Stefan Coassin·Genome MedicinePeer-reviewed·Aug 21, 2020
- A pan-genome approach to decipher variants in the highly complex tandem repeat of LPA
Chen-Shan Chin, Sairam Behera, … Fritz Joachim Sedlazeck·bioRxiv·Jun 8, 2022
- Whole genome sequence analysis of blood lipid levels in >66,000 individuals
Margaret Sunitha Selvaraj, Xihao Li, … Najib Ayas·Nature CommunicationsPeer-reviewed·Oct 11, 2022
- A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter
Stefan Coassin, Natascha Hermann‐Kleiter, … Claudia Lamina·PLoS ONEPeer-reviewed·Apr 28, 2020